Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Oct-Dec;38(4):346-357.
doi: 10.1016/j.bjhh.2016.07.004. Epub 2016 Aug 20.

Diagnosis and treatment of chronic lymphocytic leukemia: recommendations from the Brazilian Group of Chronic Lymphocytic Leukemia

Affiliations

Diagnosis and treatment of chronic lymphocytic leukemia: recommendations from the Brazilian Group of Chronic Lymphocytic Leukemia

Celso Arrais Rodrigues et al. Rev Bras Hematol Hemoter. 2016 Oct-Dec.

Erratum in

Abstract

Chronic lymphocytic leukemia is characterized by clonal proliferation and progressive accumulation of B-cell lymphocytes that typically express CD19+, CD5+ and CD23+. The lymphocytes usually infiltrate the bone marrow, peripheral blood, lymph nodes, and spleen. The diagnosis is established by immunophenotyping circulating B-lymphocytes, and prognosis is defined by two staging systems (Rai and Binet) established by physical examination and blood counts, as well as by several biological and genetic markers. In this update, we present the recommendations from the Brazilian Group of Chronic Lymphocytic Leukemia for the diagnosis and treatment of chronic lymphocytic leukemia. The following recommendations are based on an extensive literature review with the aim of contributing to more uniform patient care in Brazil and possibly in other countries with a similar social-economic profile.

Keywords: Chronic lymphocytic leukemia; Cytogenetics; Immunophenotyping; Prognosis; Staging.

PubMed Disclaimer

Similar articles

Cited by

References

    1. DeSantis C.E., Lin C.C., Mariotto A.B., Siegel R.L., Stein K.D., Kramer J.L. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64(4):252–271. - PubMed
    1. Yamamoto J.F., Goodman M.T. Patterns of leukemia incidence in the united states by subtype and demographic characteristics, 1997–2002. Cancer Causes Control. 2008;19(4):379–390. - PubMed
    1. Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29. - PubMed
    1. Lanasa M.C. Novel insights into the biology of CLL. Hematology Am Soc Hematol Educ Program. 2010;2010:70–76. - PubMed
    1. Chiorazzi N., Ferrarini M. Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities. Blood. 2011;117(6):1781–1791. - PMC - PubMed

LinkOut - more resources